Health Care

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.

adminadmin
Oct 18, 2024 - 07:00
 0  10
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Read More

Tags:

Previous Article

Crude oil prices rise slightly after four-day losing streak

Next Article

August business inventories post in line with estimates; Homebuilder sentiment r...

admin
admin

Related Posts

Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots

Supreme Court rejects appeals brought by RFK Jr-founded...

admin Jun 25, 2024  0  12

Inside the $43 million Veterans Affairs simulation hospital where doctors are piloting new tech

Inside the $43 million Veterans Affairs simulation hosp...

admin Jul 14, 2024  0  7

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

Merck tops earnings estimates on strong demand for Keyt...

admin Oct 31, 2024  0  8